(Q35062696)

6 August 2017

title

Nonsteroidal antiinflammatory drug use and lower urinary tract symptoms: results from the Boston area community health survey (English)

1 reference

6 August 2017

1 reference

Margaret A Gates

1

1 reference

6 August 2017

Susan A Hall

2

1 reference

6 August 2017

Gretchen R Chiu

3

1 reference

6 August 2017

Varant Kupelian

4

1 reference

6 August 2017

Mary P Fitzgerald

5

1 reference

6 August 2017

Carol L Link

6

1 reference

6 August 2017

John B McKinlay

7

1 reference

6 August 2017

language of work or name

English

0 references

publication date

28 February 2011

1 reference

American Journal of Epidemiology

6 August 2017

published in

1 reference

6 August 2017

volume

173

1 reference

6 August 2017

issue

9

1 reference

6 August 2017

page(s)

1022-1031

1 reference

Population impact of regulatory activity restricting prescribing of COX-2 inhibitors: ecological study

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

Inflammatory Mechanisms Associated with Prostatic Inflammation and Lower Urinary Tract Symptoms

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohort

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Boston Area Community Health survey

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

Drug-induced urinary retention: incidence, management and prevention

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

Relationship of lifestyle and clinical factors to lower urinary tract symptoms: results from Boston Area Community Health survey

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

Measuring the urologic iceberg: design and implementation of the Boston Area Community Health (BACH) Survey

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

C-reactive protein (CRP)-lowering agents

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

Nonsteroidal anti-inflammatory drugs and increased risk of acute urinary retention

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

Risk behaviours and benign prostatic hyperplasia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

Acute urinary retention associated with the use of cyclooxygenase-2 inhibitors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

Asymptomatic inflammation and/or infection in benign prostatic hyperplasia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

The Physical Activity Scale for the Elderly (PASE): development and evaluation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

Manual for Scoring Socioeconomic Status for Research on Health Behavior

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. Measurement Committee of the American Urological Association

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

A clinical investigation of the mechanism of loxoprofen, a non-steroidal anti-inflammatory drug, for patients with nocturia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

The impact of lower urinary tract symptoms and comorbidities on quality of life: the BACH and UREPIK studies

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

Effectiveness of a nonsteroidal anti-inflammatory drug for nocturia on patients with benign prostatic hyperplasia: a prospective non-randomized study of loxoprofen sodium 60 mg once daily before sleeping

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

Risk factors for lower urinary tract symptoms in a population-based sample of African-American men.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

Protective Association between Nonsteroidal Antiinflammatory Drug Use and Measures of Benign Prostatic Hyperplasia

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121220

A revised CES-D measure of depressive symptoms and a DSM-based measure of major depressive episodes in the elderly

9 December 2018

1 reference

12 December 2020

Obstruction stimulates COX-2 expression in bladder smooth muscle cells via increased mechanical stretch

1 reference

12 December 2020

A comparison between bromocriptine and indomethacin in the treatment of detrusor instability

1 reference

12 December 2020

Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium

1 reference

12 December 2020

Serum C-reactive protein concentration and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey (NHANES III)

1 reference

12 December 2020

Distribution of Inflammation, Pre-Malignant Lesions, Incidental Carcinoma in Histologically Confirmed Benign Prostatic Hyperplasia: A Retrospective Analysis

1 reference

12 December 2020

Evaluation of flurbiprofen in detrusor instability

1 reference

12 December 2020

Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age

1 reference

12 December 2020

Specificity of the American Urological Association voiding symptom index: comparison of unselected and selected samples of both sexes

1 reference

12 December 2020

Validation of a harmonized Spanish version of the IPSS: evidence of equivalence with the original American scale. International Prostate Symptom Score

1 reference

12 December 2020

Identifiers

DOI

10.1093/AJE/KWQ473

1 reference

6 August 2017

1 reference

6 August 2017

1 reference